265 related articles for article (PubMed ID: 29288767)
1. Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia.
Ward SJ; Castelli F; Reichenbach ZW; Tuma RF
Life Sci; 2018 Feb; 195():1-5. PubMed ID: 29288767
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.
Zhang M; Martin BR; Adler MW; Razdan RK; Ganea D; Tuma RF
Neuroscience; 2008 Mar; 152(3):753-60. PubMed ID: 18304750
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
[TBL] [Abstract][Full Text] [Related]
4. A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice.
Ronca RD; Myers AM; Ganea D; Tuma RF; Walker EA; Ward SJ
Life Sci; 2015 Oct; 138():72-7. PubMed ID: 26032254
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system.
Wang Q; Peng Y; Chen S; Gou X; Hu B; Du J; Lu Y; Xiong L
Stroke; 2009 Jun; 40(6):2157-64. PubMed ID: 19372445
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
[TBL] [Abstract][Full Text] [Related]
7. The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.
Reichenbach ZW; Li H; Ward SJ; Tuma RF
Neurosci Lett; 2016 Sep; 630():9-15. PubMed ID: 27453059
[TBL] [Abstract][Full Text] [Related]
8. Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
Yu SJ; Reiner D; Shen H; Wu KJ; Liu QR; Wang Y
PLoS One; 2015; 10(7):e0132487. PubMed ID: 26186541
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor 1/2 double-knockout mice develop epilepsy.
Rowley S; Sun X; Lima IV; Tavenier A; de Oliveira ACP; Dey SK; Danzer SC
Epilepsia; 2017 Dec; 58(12):e162-e166. PubMed ID: 29105060
[TBL] [Abstract][Full Text] [Related]
10. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
Zheng L; Wu X; Dong X; Ding X; Song C
Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
[TBL] [Abstract][Full Text] [Related]
11. The neuroprotective impact of the leak potassium channel TASK1 on stroke development in mice.
Meuth SG; Kleinschnitz C; Broicher T; Austinat M; Braeuninger S; Bittner S; Fischer S; Bayliss DA; Budde T; Stoll G; Wiendl H
Neurobiol Dis; 2009 Jan; 33(1):1-11. PubMed ID: 18930826
[TBL] [Abstract][Full Text] [Related]
12. Increased severity of stroke in CB1 cannabinoid receptor knock-out mice.
Parmentier-Batteur S; Jin K; Mao XO; Xie L; Greenberg DA
J Neurosci; 2002 Nov; 22(22):9771-5. PubMed ID: 12427832
[TBL] [Abstract][Full Text] [Related]
13. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
14. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
Deng L; Cornett BL; Mackie K; Hohmann AG
Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
16. Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Engel MA; Kellermann CA; Burnat G; Hahn EG; Rau T; Konturek PC
J Physiol Pharmacol; 2010 Feb; 61(1):89-97. PubMed ID: 20228420
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.
Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB
J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation.
Roelandt T; Heughebaert C; Bredif S; Giddelo C; Baudouin C; Msika P; Roseeuw D; Uchida Y; Elias PM; Hachem JP
Exp Dermatol; 2012 Sep; 21(9):688-93. PubMed ID: 22897575
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia.
Ma L; Zhu Z; Zhao Y; Hou L; Wang Q; Xiong L; Zhu X; Jia J; Chen S
Curr Neurovasc Res; 2011 May; 8(2):145-52. PubMed ID: 21443454
[TBL] [Abstract][Full Text] [Related]
20. Impaired vessel relaxation response and increased infarct size in smooth muscle cannabinoid receptor 1 knockout mice.
Wang LN; Xing MD; Qu WT; Wang CB; Liu ZQ; Han J; Ren W; Qiao YN
Microvasc Res; 2022 Jan; 139():104263. PubMed ID: 34655603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
